ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Psoriasis Therapeutics Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-28R13138
Home | Market Reports | Health| Health Conditions| Skin Conditions
Global Psoriasis Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Psoriasis Therapeutics Market Insights, Forecast to 2030

Code: QYRE-Auto-28R13138
Report
December 2024
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astellas Pharma Inc
Astrazeneca plc
Boehringer Ingelheim GmbH
F. Hofffmann-La Roche
GlaxoSmithKline PLC
Merck& Co. Inc
Valeant Pharmaceuticals International Inc
Biocon Ltd.
Eli Lilly and Company
G & W Laboratories Inc.

Psoriasis Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Psoriasis Therapeutics Market

Psoriasis Therapeutics Market

Psoriasis is considered to be a persistent skin disorder that is characterized mainly by skin irritation and scaly rashes where the skin cells multiply up to 10 times faster than normal. Psoriasis majorly affects the knees, elbows, and scalp. The major objective of the therapy for this disease is to stop the skin cells from growing so quickly. The therapeutic approach for psoriasis depends upon the severity and amount of skin affected by the same.
Market Analysis and Insights: Global Psoriasis Therapeutics Market
The global Psoriasis Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Psoriasis Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Psoriasis Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Psoriasis Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Psoriasis Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Psoriasis Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Psoriasis Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Psoriasis Therapeutics Market Report

Report Metric Details
Report Name Psoriasis Therapeutics Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Astellas Pharma Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, F. Hofffmann-La Roche, GlaxoSmithKline plc, Merck & Co., Inc., Valeant Pharmaceuticals International, Inc., Biocon Limited, Eli Lilly and Company, G & W Laboratories Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Psoriasis Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Psoriasis Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Psoriasis Therapeutics revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Psoriasis Therapeutics Market report?

Ans: The main players in the Psoriasis Therapeutics Market are Astellas Pharma Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, F. Hofffmann-La Roche, GlaxoSmithKline plc, Merck & Co., Inc., Valeant Pharmaceuticals International, Inc., Biocon Limited, Eli Lilly and Company, G & W Laboratories Inc.

What are the Application segmentation covered in the Psoriasis Therapeutics Market report?

Ans: The Applications covered in the Psoriasis Therapeutics Market report are Oral, Parenteral, Topical

What are the Type segmentation covered in the Psoriasis Therapeutics Market report?

Ans: The Types covered in the Psoriasis Therapeutics Market report are TNF Inhibitors, PDE4 Inhibitors, Interleukin Blockers, Others

Recommended Reports

Autoimmune & Inflammation

Dermatology & Skin Care

Therapeutics Market Overview

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriasis Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 TNF Inhibitors
1.2.3 PDE4 Inhibitors
1.2.4 Interleukin Blockers
1.2.5 Others
1.3 Market by Application
1.3.1 Global Psoriasis Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Oral
1.3.3 Parenteral
1.3.4 Topical
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psoriasis Therapeutics Market Perspective (2019-2030)
2.2 Global Psoriasis Therapeutics Growth Trends by Region
2.2.1 Psoriasis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Psoriasis Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Psoriasis Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Psoriasis Therapeutics Market Dynamics
2.3.1 Psoriasis Therapeutics Industry Trends
2.3.2 Psoriasis Therapeutics Market Drivers
2.3.3 Psoriasis Therapeutics Market Challenges
2.3.4 Psoriasis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Psoriasis Therapeutics by Players
3.1.1 Global Psoriasis Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Psoriasis Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Psoriasis Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Psoriasis Therapeutics Market Concentration Ratio
3.4.1 Global Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriasis Therapeutics Revenue in 2023
3.5 Global Key Players of Psoriasis Therapeutics Head office and Area Served
3.6 Global Key Players of Psoriasis Therapeutics, Product and Application
3.7 Global Key Players of Psoriasis Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriasis Therapeutics Breakdown Data by Type
4.1 Global Psoriasis Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Psoriasis Therapeutics Forecasted Market Size by Type (2025-2030)
5 Psoriasis Therapeutics Breakdown Data by Application
5.1 Global Psoriasis Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Psoriasis Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Psoriasis Therapeutics Market Size (2019-2030)
6.2 North America Psoriasis Therapeutics Market Size by Type
6.2.1 North America Psoriasis Therapeutics Market Size by Type (2019-2024)
6.2.2 North America Psoriasis Therapeutics Market Size by Type (2025-2030)
6.2.3 North America Psoriasis Therapeutics Market Share by Type (2019-2030)
6.3 North America Psoriasis Therapeutics Market Size by Application
6.3.1 North America Psoriasis Therapeutics Market Size by Application (2019-2024)
6.3.2 North America Psoriasis Therapeutics Market Size by Application (2025-2030)
6.3.3 North America Psoriasis Therapeutics Market Share by Application (2019-2030)
6.4 North America Psoriasis Therapeutics Market Size by Country
6.4.1 North America Psoriasis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Psoriasis Therapeutics Market Size by Country (2019-2024)
6.4.3 North America Psoriasis Therapeutics Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Psoriasis Therapeutics Market Size (2019-2030)
7.2 Europe Psoriasis Therapeutics Market Size by Type
7.2.1 Europe Psoriasis Therapeutics Market Size by Type (2019-2024)
7.2.2 Europe Psoriasis Therapeutics Market Size by Type (2025-2030)
7.2.3 Europe Psoriasis Therapeutics Market Share by Type (2019-2030)
7.3 Europe Psoriasis Therapeutics Market Size by Application
7.3.1 Europe Psoriasis Therapeutics Market Size by Application (2019-2024)
7.3.2 Europe Psoriasis Therapeutics Market Size by Application (2025-2030)
7.3.3 Europe Psoriasis Therapeutics Market Share by Application (2019-2030)
7.4 Europe Psoriasis Therapeutics Market Size by Country
7.4.1 Europe Psoriasis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Psoriasis Therapeutics Market Size by Country (2019-2024)
7.4.3 Europe Psoriasis Therapeutics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Psoriasis Therapeutics Market Size (2019-2030)
8.2 China Psoriasis Therapeutics Market Size by Type
8.2.1 China Psoriasis Therapeutics Market Size by Type (2019-2024)
8.2.2 China Psoriasis Therapeutics Market Size by Type (2025-2030)
8.2.3 China Psoriasis Therapeutics Market Share by Type (2019-2030)
8.3 China Psoriasis Therapeutics Market Size by Application
8.3.1 China Psoriasis Therapeutics Market Size by Application (2019-2024)
8.3.2 China Psoriasis Therapeutics Market Size by Application (2025-2030)
8.3.3 China Psoriasis Therapeutics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Psoriasis Therapeutics Market Size (2019-2030)
9.2 Asia Psoriasis Therapeutics Market Size by Type
9.2.1 Asia Psoriasis Therapeutics Market Size by Type (2019-2024)
9.2.2 Asia Psoriasis Therapeutics Market Size by Type (2025-2030)
9.2.3 Asia Psoriasis Therapeutics Market Share by Type (2019-2030)
9.3 Asia Psoriasis Therapeutics Market Size by Application
9.3.1 Asia Psoriasis Therapeutics Market Size by Application (2019-2024)
9.3.2 Asia Psoriasis Therapeutics Market Size by Application (2025-2030)
9.3.3 Asia Psoriasis Therapeutics Market Share by Application (2019-2030)
9.4 Asia Psoriasis Therapeutics Market Size by Region
9.4.1 Asia Psoriasis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Psoriasis Therapeutics Market Size by Region (2019-2024)
9.4.3 Asia Psoriasis Therapeutics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Psoriasis Therapeutics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Psoriasis Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Psoriasis Therapeutics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Psoriasis Therapeutics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Psoriasis Therapeutics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Psoriasis Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Psoriasis Therapeutics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Psoriasis Therapeutics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Psoriasis Therapeutics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Psoriasis Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Psoriasis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Psoriasis Therapeutics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Psoriasis Therapeutics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Company Details
11.1.2 Astellas Pharma Inc. Business Overview
11.1.3 Astellas Pharma Inc. Psoriasis Therapeutics Introduction
11.1.4 Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2019-2024)
11.1.5 Astellas Pharma Inc. Recent Developments
11.2 AstraZeneca plc
11.2.1 AstraZeneca plc Company Details
11.2.2 AstraZeneca plc Business Overview
11.2.3 AstraZeneca plc Psoriasis Therapeutics Introduction
11.2.4 AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2019-2024)
11.2.5 AstraZeneca plc Recent Developments
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Details
11.3.2 Boehringer Ingelheim GmbH Business Overview
11.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Introduction
11.3.4 Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2019-2024)
11.3.5 Boehringer Ingelheim GmbH Recent Developments
11.4 F. Hofffmann-La Roche
11.4.1 F. Hofffmann-La Roche Company Details
11.4.2 F. Hofffmann-La Roche Business Overview
11.4.3 F. Hofffmann-La Roche Psoriasis Therapeutics Introduction
11.4.4 F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2019-2024)
11.4.5 F. Hofffmann-La Roche Recent Developments
11.5 GlaxoSmithKline plc
11.5.1 GlaxoSmithKline plc Company Details
11.5.2 GlaxoSmithKline plc Business Overview
11.5.3 GlaxoSmithKline plc Psoriasis Therapeutics Introduction
11.5.4 GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2019-2024)
11.5.5 GlaxoSmithKline plc Recent Developments
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Company Details
11.6.2 Merck & Co., Inc. Business Overview
11.6.3 Merck & Co., Inc. Psoriasis Therapeutics Introduction
11.6.4 Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2019-2024)
11.6.5 Merck & Co., Inc. Recent Developments
11.7 Valeant Pharmaceuticals International, Inc.
11.7.1 Valeant Pharmaceuticals International, Inc. Company Details
11.7.2 Valeant Pharmaceuticals International, Inc. Business Overview
11.7.3 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Introduction
11.7.4 Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2019-2024)
11.7.5 Valeant Pharmaceuticals International, Inc. Recent Developments
11.8 Biocon Limited
11.8.1 Biocon Limited Company Details
11.8.2 Biocon Limited Business Overview
11.8.3 Biocon Limited Psoriasis Therapeutics Introduction
11.8.4 Biocon Limited Revenue in Psoriasis Therapeutics Business (2019-2024)
11.8.5 Biocon Limited Recent Developments
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Details
11.9.2 Eli Lilly and Company Business Overview
11.9.3 Eli Lilly and Company Psoriasis Therapeutics Introduction
11.9.4 Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2019-2024)
11.9.5 Eli Lilly and Company Recent Developments
11.10 G & W Laboratories Inc.
11.10.1 G & W Laboratories Inc. Company Details
11.10.2 G & W Laboratories Inc. Business Overview
11.10.3 G & W Laboratories Inc. Psoriasis Therapeutics Introduction
11.10.4 G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2019-2024)
11.10.5 G & W Laboratories Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Astellas Pharma Inc
Astrazeneca plc
Boehringer Ingelheim GmbH
F. Hofffmann-La Roche
GlaxoSmithKline PLC
Merck& Co. Inc
Valeant Pharmaceuticals International Inc
Biocon Ltd.
Eli Lilly and Company
G & W Laboratories Inc.
List of Tables
    Table 1. Global Psoriasis Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of TNF Inhibitors
    Table 3. Key Players of PDE4 Inhibitors
    Table 4. Key Players of Interleukin Blockers
    Table 5. Key Players of Others
    Table 6. Global Psoriasis Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Psoriasis Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Psoriasis Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Psoriasis Therapeutics Market Share by Region (2019-2024)
    Table 10. Global Psoriasis Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Psoriasis Therapeutics Market Share by Region (2025-2030)
    Table 12. Psoriasis Therapeutics Market Trends
    Table 13. Psoriasis Therapeutics Market Drivers
    Table 14. Psoriasis Therapeutics Market Challenges
    Table 15. Psoriasis Therapeutics Market Restraints
    Table 16. Global Psoriasis Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Psoriasis Therapeutics Revenue Share by Players (2019-2024)
    Table 18. Global Top Psoriasis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Therapeutics as of 2023)
    Table 19. Global Psoriasis Therapeutics Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Psoriasis Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Psoriasis Therapeutics, Headquarters and Area Served
    Table 22. Global Key Players of Psoriasis Therapeutics, Product and Application
    Table 23. Global Key Players of Psoriasis Therapeutics, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Psoriasis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Psoriasis Therapeutics Revenue Market Share by Type (2019-2024)
    Table 27. Global Psoriasis Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Psoriasis Therapeutics Revenue Market Share by Type (2025-2030)
    Table 29. Global Psoriasis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Psoriasis Therapeutics Revenue Share by Application (2019-2024)
    Table 31. Global Psoriasis Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Psoriasis Therapeutics Revenue Share by Application (2025-2030)
    Table 33. North America Psoriasis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Psoriasis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Psoriasis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Psoriasis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Psoriasis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Psoriasis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Psoriasis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Psoriasis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Psoriasis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Psoriasis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Psoriasis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Psoriasis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Psoriasis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Psoriasis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Psoriasis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Psoriasis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Psoriasis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Psoriasis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Psoriasis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Psoriasis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Psoriasis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Psoriasis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Psoriasis Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Psoriasis Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Psoriasis Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Psoriasis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Psoriasis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Psoriasis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Psoriasis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Psoriasis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Psoriasis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Psoriasis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Astellas Pharma Inc. Company Details
    Table 66. Astellas Pharma Inc. Business Overview
    Table 67. Astellas Pharma Inc. Psoriasis Therapeutics Product
    Table 68. Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)
    Table 69. Astellas Pharma Inc. Recent Developments
    Table 70. AstraZeneca plc Company Details
    Table 71. AstraZeneca plc Business Overview
    Table 72. AstraZeneca plc Psoriasis Therapeutics Product
    Table 73. AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)
    Table 74. AstraZeneca plc Recent Developments
    Table 75. Boehringer Ingelheim GmbH Company Details
    Table 76. Boehringer Ingelheim GmbH Business Overview
    Table 77. Boehringer Ingelheim GmbH Psoriasis Therapeutics Product
    Table 78. Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)
    Table 79. Boehringer Ingelheim GmbH Recent Developments
    Table 80. F. Hofffmann-La Roche Company Details
    Table 81. F. Hofffmann-La Roche Business Overview
    Table 82. F. Hofffmann-La Roche Psoriasis Therapeutics Product
    Table 83. F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)
    Table 84. F. Hofffmann-La Roche Recent Developments
    Table 85. GlaxoSmithKline plc Company Details
    Table 86. GlaxoSmithKline plc Business Overview
    Table 87. GlaxoSmithKline plc Psoriasis Therapeutics Product
    Table 88. GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)
    Table 89. GlaxoSmithKline plc Recent Developments
    Table 90. Merck & Co., Inc. Company Details
    Table 91. Merck & Co., Inc. Business Overview
    Table 92. Merck & Co., Inc. Psoriasis Therapeutics Product
    Table 93. Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)
    Table 94. Merck & Co., Inc. Recent Developments
    Table 95. Valeant Pharmaceuticals International, Inc. Company Details
    Table 96. Valeant Pharmaceuticals International, Inc. Business Overview
    Table 97. Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Product
    Table 98. Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)
    Table 99. Valeant Pharmaceuticals International, Inc. Recent Developments
    Table 100. Biocon Limited Company Details
    Table 101. Biocon Limited Business Overview
    Table 102. Biocon Limited Psoriasis Therapeutics Product
    Table 103. Biocon Limited Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)
    Table 104. Biocon Limited Recent Developments
    Table 105. Eli Lilly and Company Company Details
    Table 106. Eli Lilly and Company Business Overview
    Table 107. Eli Lilly and Company Psoriasis Therapeutics Product
    Table 108. Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)
    Table 109. Eli Lilly and Company Recent Developments
    Table 110. G & W Laboratories Inc. Company Details
    Table 111. G & W Laboratories Inc. Business Overview
    Table 112. G & W Laboratories Inc. Psoriasis Therapeutics Product
    Table 113. G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2019-2024) & (US$ Million)
    Table 114. G & W Laboratories Inc. Recent Developments
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Psoriasis Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Psoriasis Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. TNF Inhibitors Features
    Figure 4. PDE4 Inhibitors Features
    Figure 5. Interleukin Blockers Features
    Figure 6. Others Features
    Figure 7. Global Psoriasis Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Psoriasis Therapeutics Market Share by Application: 2023 VS 2030
    Figure 9. Oral Case Studies
    Figure 10. Parenteral Case Studies
    Figure 11. Topical Case Studies
    Figure 12. Psoriasis Therapeutics Report Years Considered
    Figure 13. Global Psoriasis Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Psoriasis Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Psoriasis Therapeutics Market Share by Region: 2023 VS 2030
    Figure 16. Global Psoriasis Therapeutics Market Share by Players in 2023
    Figure 17. Global Top Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Therapeutics as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Psoriasis Therapeutics Revenue in 2023
    Figure 19. North America Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Psoriasis Therapeutics Market Share by Type (2019-2030)
    Figure 21. North America Psoriasis Therapeutics Market Share by Application (2019-2030)
    Figure 22. North America Psoriasis Therapeutics Market Share by Country (2019-2030)
    Figure 23. United States Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Psoriasis Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Psoriasis Therapeutics Market Share by Type (2019-2030)
    Figure 27. Europe Psoriasis Therapeutics Market Share by Application (2019-2030)
    Figure 28. Europe Psoriasis Therapeutics Market Share by Country (2019-2030)
    Figure 29. Germany Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Psoriasis Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Psoriasis Therapeutics Market Share by Type (2019-2030)
    Figure 37. China Psoriasis Therapeutics Market Share by Application (2019-2030)
    Figure 38. Asia Psoriasis Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Psoriasis Therapeutics Market Share by Type (2019-2030)
    Figure 40. Asia Psoriasis Therapeutics Market Share by Application (2019-2030)
    Figure 41. Asia Psoriasis Therapeutics Market Share by Region (2019-2030)
    Figure 42. Japan Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Psoriasis Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Psoriasis Therapeutics Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Psoriasis Therapeutics Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Psoriasis Therapeutics Market Share by Country (2019-2030)
    Figure 52. Brazil Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Psoriasis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Astellas Pharma Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)
    Figure 59. AstraZeneca plc Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)
    Figure 60. Boehringer Ingelheim GmbH Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)
    Figure 61. F. Hofffmann-La Roche Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)
    Figure 62. GlaxoSmithKline plc Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)
    Figure 63. Merck & Co., Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)
    Figure 64. Valeant Pharmaceuticals International, Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)
    Figure 65. Biocon Limited Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)
    Figure 66. Eli Lilly and Company Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)
    Figure 67. G & W Laboratories Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Psoriatic Arthritis Therapeutics Drug Market Insights Forecast to 2030
Global Biopharmaceuticals for Psoriasis Market Research Report 2024
Global Psoriasis Treatment Drugs Market Research Report 2025
Psoriasis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Scleroderma Therapeutics Market Insights Forecast to 2030
Global Plaque Psoriasis Treatment Medications Market Research Report 2024
Global Psoriatic Arthritis Treatment Drugs Market Research Report 2025
Psoriatic Arthritis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Atopic Dermatitis Therapeutics Market Insights Forecast to 2030
Global Psoriasis Biologics Drugs Market Research Report 2025
Global Inflammatory Skin Diseases Treatment Market Research Report 2024
Global Scleroderma Drug Market Insights Forecast to 2030
Global Chronic Plaque Psoriasis Therapeutics Market Research Report 2024
Global Pediatric Psoriasis Market Research Report 2024
Global Moderate to Severe Plaque Psoriasis Medications Market Research Report 2024
Global Dermatological Remedies Market Insights Forecast to 2030
Global Rosacea Therapeutics Market Insights Forecast to 2030
Global Dermatology Diagnostic and Therapeutic Devices Market Insights Forecast to 2030
Global Skin Allergy Treatment Market Insights Forecast to 2030
Global Treatment of Skin Fibrosis Market Insights Forecast to 2030

RELATED REPORTS

Global Chronic Idiopathic Urticaria Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38H16391
Tue Sep 23 00:00:00 UTC 2025

Add to Cart

Global Fungal Skin Disease Diagnostic Equipment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17T16810
Mon Sep 22 00:00:00 UTC 2025

Add to Cart

Global UVB Vitiligo Phototherapy Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z16496
Mon Sep 22 00:00:00 UTC 2025

Add to Cart

Global Vitiligo Phototherapy Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15I16746
Mon Sep 22 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions